PolyModels Hub develops ModelFlow, an integrated platform that combines AI, advanced modelling, simulation, and data-driven workflows to accelerate the design, testing, and optimisation of drug manufacturing processes. By unifying process knowledge and workflow management in a single environment, the software helps scientists and engineers move candidates from lab experiments to large-scale production faster and with lower cost and risk. Within its first 18 months, the company reports delivering significant impact for large pharmaceutical partners, prompting those collaborations to expand globally. Following its Series A financing, PolyModels Hub intends to grow its engineering and product teams and further enhance its core platform. Future plans include rolling out scalable solutions for process and regulatory workflows and deepening capabilities for complex biologics. The ultimate goal is to support the broader digitalisation of biopharma process development, enabling quicker delivery of new medicines to patients.

Total raised

$11M

Funding rounds

2

Latest round

Series A

Latest activity

Nov 2025